Stockreport

Cardiff Oncology Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF US$0.93 loss per share (further deteriorated from US$0.89 loss in FY 2022). All figures shown in the chart above are for the trailing 12 month (TTM) period Cardiff [Read more]